KRT81 Knockdown Inhibits Malignant Progression of Melanoma Through Regulating Interleukin-8.

KRT81 is involved in carcinogenesis and progression of many types of human cancers. However, little is known about the role of KRT81 in melanoma. In this study, we identified that KRT81 expression is upregulated in melanoma tissues compared with corresponding adjacent nontumor tissues. Overexpression of KRT81 was also found in human melanoma cell lines. Cell functional studies have shown that KRT81 knockdown could inhibit proliferation, colony formation, migration, invasion, and promote apoptosis of A375 cells. Consistently, in vivo tumorigenesis experiments showed that KRT81 knockdown significantly suppressed the growth of xenograft tumors. Moreover, KRT81 knockdown increased the chemosensitivity of A375 cells to DDP. Mechanical exploration revealed that KRT81 knockdown mediated the downregulation of inflammatory cytokine interleukin-8 (IL-8). In conclusion, these findings indicate that downregulation of KRT81 could inhibit progression of melanoma by regulating IL-8. Therefore, KRT81 represents a potential therapeutic target for melanoma therapy.

Citation

Kun Zhang, Yan Liang, Wancong Zhang, Ning Zeng, Shijie Tang, Ruoxi Tian. KRT81 Knockdown Inhibits Malignant Progression of Melanoma Through Regulating Interleukin-8. DNA and cell biology. 2021 Oct;40(10):1290-1297

Mesh Tags

Substances

PMID: 34591651

search → result